MTOR and Alzheimer disease: It is likely that various aspects of the restoration of circadian SGLT2-mTOR modulation, such as its effects on anabolic (cell growth, protein synthesis,) and catabolic (lysosomal function, autophagy) processes are responsible for sustaining metabolic dysfunction in AD.